James R. Kasinger
General Counsel and Secretary · 5 filings · Latest: May 29, 2026
CRISPR Therapeutics AG
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRSP | James R. Kasinger | General Counsel and Secretary | Mar 23, 2026 | Sale | $46.78 | 3,182 | $148.9K | 94,308 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Mar 20, 2026 | Option Exercise | — | 6,250 | — | 97,490 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Mar 16, 2026 | Sale | $48.26 | 3,450 | $166.5K | 91,240 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Mar 14, 2026 | Option Exercise | — | 6,875 | — | 94,690 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Mar 11, 2026 | Sale | $52.80 | 2,800 | $147.8K | 87,815 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Mar 10, 2026 | Option Exercise | — | 5,500 | — | 90,615 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Feb 19, 2026 | Sale | $52.58 | 2,112 | $111.0K | 85,115 | |
CRSP | James R. Kasinger | General Counsel and Secretary | Feb 18, 2026 | Option Exercise | — | 3,825 | — | 87,227 |